Lavender and Ember Health Link Psychiatry with Ketamine Care
Patients navigating treatment-resistant depression often face a fragmented healthcare landscape, moving between isolated providers with little communication. A four-year partnership between Lavender Psychiatry and Ember Health aims to bridge this gap, integrating ongoing psychiatric management with specialized IV ketamine therapy through a coordinated, bidirectional referral model.

Since 2022, the collaboration has connected 52 psychiatric nurse practitioners from Lavender with Ember’s interventional clinical team. This co-care framework allows providers to share clinical history and treatment goals, ensuring that patients receiving ketamine therapy maintain consistent support for their broader medication management and diagnostic needs. By removing the burden of care coordination from the patient, the organizations address a recurring failure in modern mental health systems where specialized interventions are treated as silos.
Dr. Nico Grundmann, co-founder of Ember Health, notes that the practice reports an 84% positive response rate for depression, bolstered by this deep integration with ongoing psychiatric care. For Lavender, the model serves as a blueprint for maintaining continuity as patient needs grow more complex. The partnership recently expanded its scope beyond clinical practice, hosting a community forum in New York City this May to advocate for more interconnected mental health ecosystems. As both organizations continue to scale, they emphasize that keeping the primary clinician involved during interventional procedures is essential for long-term patient stability.
Comments (0)
No comments yet. Be the first!